KCM Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.7M Sell
87,251
-270
-0.3% -$96.3K 1.02% 31
2025
Q4
$28.6M Sell
87,521
-1,273
-1% -$404K 0.92% 33
2025
Q3
$25.1M Sell
88,794
-1,041
-1% -$302K 0.81% 36
2025
Q2
$25.1M Sell
89,835
-124
-0.1% -$35.1K 0.84% 35
2025
Q1
$28M Sell
89,959
-1,127
-1% -$333K 1.01% 32
2024
Q4
$23.7M Sell
91,086
-356
-0.4% -$106K 0.82% 36
2024
Q3
$29.5M Sell
91,442
-651
-0.7% -$213K 1% 32
2024
Q2
$28.8M Buy
92,093
+968
+1% +$284K 1.03% 30
2024
Q1
$25.9M Buy
91,125
+343
+0.4% +$100K 0.96% 32
2023
Q4
$26.1M Buy
90,782
+143
+0.2% +$39K 1.04% 27
2023
Q3
$24.4M Sell
90,639
-332
-0.4% -$82.9K 1.05% 28
2023
Q2
$20.2M Sell
90,971
-574
-0.6% -$133K 0.81% 37
2023
Q1
$22.1M Sell
91,545
-193
-0.2% -$47.4K 0.9% 35
2022
Q4
$24.1M Buy
91,738
+482
+0.5% +$129K 1.04% 27
2022
Q3
$20.6M Sell
91,256
-2,187
-2% -$530K 0.95% 29
2022
Q2
$22.7M Sell
93,443
-1,362
-1% -$334K 0.99% 26
2022
Q1
$22.9M Buy
94,805
+653
+0.7% +$150K 0.84% 38
2021
Q4
$21.2M Sell
94,152
-20,692
-18% -$4.37M 0.74% 43
2021
Q3
$24.4M Buy
114,844
+4,635
+4% +$1.07M 0.97% 30
2021
Q2
$26.9M Buy
110,209
+5,683
+5% +$1.4M 1.09% 27
2021
Q1
$26M Buy
104,526
+12,121
+13% +$2.89M 1.15% 26
2020
Q4
$21.2M Buy
92,405
+6,934
+8% +$1.6M 1.02% 29
2020
Q3
$21.7M Buy
85,471
+9,960
+13% +$2.47M 1.2% 21
2020
Q2
$17.8M Buy
75,511
+5,281
+8% +$1.2M 1% 30
2020
Q1
$14.2M Sell
70,230
-50
-0.1% -$10.9K 0.96% 38
2019
Q4
$16.9M Buy
70,280
+5,899
+9% +$1.3M 0.92% 33
2019
Q3
$12.5M Buy
64,381
+6,783
+12% +$1.3M 0.72% 43
2019
Q2
$10.6M Buy
57,598
+6,943
+14% +$1.24M 0.64% 48
2019
Q1
$9.62M Buy
50,655
+5,417
+12% +$1.03M 0.62% 48
2018
Q4
$8.81M Buy
45,238
+7,451
+20% +$1.45M 0.58% 48
2018
Q3
$7.83M Buy
37,787
+23,342
+162% +$4.6M 0.45% 57
2018
Q2
$2.67M Buy
14,445
+523
+4% +$92.5K 0.16% 127
2018
Q1
$2.37M Sell
13,922
-2,215
-14% -$407K 0.14% 147
2017
Q4
$2.81M Buy
16,137
+176
+1% +$31.1K 0.16% 135
2017
Q3
$2.98M Buy
15,961
+688
+5% +$122K 0.18% 132
2017
Q2
$2.63M Sell
15,273
-208
-1% -$33.8K 0.16% 153
2017
Q1
$2.54M Sell
15,481
-695
-4% -$115K 0.16% 150
2016
Q4
$2.37M Buy
16,176
+380
+2% +$57.2K 0.16% 153
2016
Q3
$2.63M Sell
15,796
-235
-1% -$39.7K 0.18% 134
2016
Q2
$2.44M Buy
16,031
+797
+5% +$124K 0.17% 147
2016
Q1
$2.28M Sell
15,234
-125
-0.8% -$18.6K 0.17% 148
2015
Q4
$2.49M Sell
15,359
-404
-3% -$63.5K 0.2% 135
2015
Q3
$2.18M Buy
15,763
+1,542
+11% +$243K 0.18% 151
2015
Q2
$2.18M Sell
14,221
-420
-3% -$67.3K 0.17% 161
2015
Q1
$2.34M Buy
14,641
+1,353
+10% +$213K 0.19% 146
2014
Q4
$2.12M Buy
13,288
+115
+0.9% +$17.9K 0.18% 153
2014
Q3
$1.85M Buy
13,173
+1
+0% +$131 0.17% 161
2014
Q2
$1.56M Buy
13,172
+1,200
+10% +$139K 0.15% 178
2014
Q1
$1.48M Sell
11,972
-668
-5% -$81K 0.15% 175
2013
Q4
$1.44M Buy
12,640
+1,650
+15% +$188K 0.16% 168
2013
Q3
$1.23M Hold
10,990
0.15% 177
2013
Q2
$1.08M Buy
+10,990
New +$1.14M 0.13% 185

Other funds holding AMGN

KCM Investment Advisors's AMGN Position: Q1 2026 in Review

KCM Investment Advisors reduced its Amgen (AMGN) stake by 0.31% in Q1 2026, selling an estimated $96.3K and leaving 87,251 shares worth $30.7M. The position accounts for 1.02% of the portfolio, ranked #31.

KCM Investment Advisors first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • KCM Investment Advisors held 87,251 shares of Amgen worth $30.7M as of Q1 2026.
  • KCM Investment Advisors sold 270 Amgen shares in Q1 2026, an estimated $96.3K.
  • Amgen made up 1.02% of KCM Investment Advisors's portfolio in Q1 2026, its #31 holding.
  • KCM Investment Advisors first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on KCM Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.